search
attachments
weblink
advanced
Overview
Content Tools
Tasks
Basel, Switzerland, July 26, 2012
Sustained sales and earnings growth
- Sales $8.3 billion, up 7 percent; up 10 percent at constant exchange rates (CER)1
- Strong northern hemisphere performance
- Corn seed sales up 47 percent
- trait milestones reached, royalty recognition
- strong underlying growth
- EBITDA up 15 percent at CER
- Net income $1.5 billion, up 5 percent
- Earnings per share2 $17.17, up 10 percent
Reported Financial Highlights
| 1st Half 2012 | 1st Half 2011 | Actual | CER1 | |
| $m | $m | % | % | |
| Sales | 8,265 | 7,702 | + 7 | + 10 |
| Operating income | 1,839 | 1,830 | - | |
| Net income3 | 1,500 | 1,427 | + 5 | |
| EBITDA | 2,268 | 2,149 | + 6 | + 15 |
| Earnings per share2 | $17.17 | $15.60 | +10 |
2 Excluding restructuring and impairment; EPS on a fully-diluted basis.
3 Net income to shareholders of Syngenta AG (equivalent to diluted earnings per share of $16.31).
Mike Mack, Chief Executive Officer, said:
“In the first half of 2012 we continued implementation of our integrated strategy while again delivering double digit top line growth. Sales were strong in the key northern hemisphere season despite a cold start in Europe followed by heavy rain in the second quarter. An excellent performance in North America reflected early plantings and widespread optimism for the season coupled with strong demand for our resistance management offers. Our technology investments in corn traits resulted in market share gains in Latin America and royalty income from third parties. We continued to invest in growing the business globally while delivering a substantial increase in underlying profitability.
“Weather conditions in Europe and more recently North America have resulted in sharp increases in crop prices. This has again brought to the fore the volatility frequently confronting growers. The challenge of food production is essentially a global one, but grower responses are driven by a multitude of local influences and considerations. The breadth of our toolbox allows us not only to respond to but also inform the choices being made daily in farms around the world. The need for technology in agriculture was never greater than it is today, and we believe that our integrated strategy can enhance the value of that technology for customers and shareholders alike.”
Full PDF version
Announcements and Meetings
| Crop update | September 24-26, 2012 | |
| Third quarter trading statement 2012 | October 23, 2012 | |
| Full year results 2012 | February 06, 2013 | |
| First quarter trading statement 2013 | April 18, 2013 |
2012-07-26
P-12-334
- 2nd quarter 2012:
- Sales up 6% and EBIT before special items up 11%
compared with previous year’s quarter - Strong business in Agricultural Solutions
- Significant decrease in growth in China
- Sales up 6% and EBIT before special items up 11%
- Outlook full year 2012: increase in sales and earnings targeted
At the presentation of the company’s second-quarter results, Dr. Kurt Bock, Chairman of the Board of Executive Directors, commented on the growing economic risks: “Our customers are continuing to act cautiously and are reducing their inventories, also in expectation of falling prices due to declining raw material costs.” In addition, the Chinese growth engine has started to stall leading to a decrease in BASF’s sales in local-currency terms in Asia in the second quarter, as they also did in the first quarter of 2012, explained Bock.
BASF confirms outlook for full year 2012
A look at the economic developments in the past months and at the order books have led BASF to become more cautious about its expectations for the global economy in 2012 than originally expected at the beginning of the year (previous forecast in parenthesis):
- Growth of gross domestic product: 2.3% (2.7%)
- Growth in industrial production: 3.4% (4.1%)
- Growth in chemical production: 3.5% (4.1%)
- An average euro/dollar exchange rate of $1.30 per euro
- An average oil price of $110/barrel in 2012
Bock said: “It remains our goal to increase sales and earnings compared with the second half of 2011. Our forecast is especially supported by the resumption of our crude oil production in Libya. It is unlikely that the earnings from our chemicals business will match the level of the previous year. We still aim to exceed the 2011 record levels in sales and EBIT before special items.”
To counter the challenges of the markets and the great political and macroeconomic uncertainties, BASF wants to protect its margins and create value. The excellence program, STEP, announced in November 2011, which is expected to contribute around €1 billion to earnings each year as of the end of 2015, is fully on track. Measures will be accelerated and spending carefully analyzed. BASF is continuing to optimize its working capital, as is demonstrated by the good cash flow development in the second quarter. Although the company had planned a slight increase in its workforce in 2012, especially in emerging markets, it will slow this down due to the lack of visibility as to when business in Asia will pick up again.
Second-quarter business development in the segments
In the Chemicals segment, sales were slightly below the level of the previous second quarter, primarily due to lower sales volumes. Along with weaker demand, the optimization of the supply chain for steam cracker products, carried out in the third quarter of 2011, contributed to this decline in volumes. Sales to Styrolution Group companies had a positive impact on sales development for the segment. Earnings decreased significantly as a result of falling margins and the scheduled maintenance shutdown of several plants.
Sales in the Plastics segment surpassed the level of the second quarter of 2011. While sales volumes were weaker, positive currency effects in particular boosted sales growth. Lower margins for some basic products led to a significant decline in earnings.
Sales in the Performance Products segment grew slightly compared with the previous second quarter, largely as a result of positive currency effects. Sales volumes were lower. Increased raw material costs could not be fully passed on through higher sales prices. Earnings therefore declined due to lower margins and volumes.
Sales in the Functional Solutions segment increased. In addition to the inclusion of 50% of the Korean joint venture Heesung Catalysts Corporation, positive currency effects were particularly responsible for sales growth. This was partially offset by lower prices, especially in precious metals. Earnings did not match the level of the previous second quarter, primarily as a result of higher raw material costs.
Business was very successful in the Agricultural Solutions segment. Sales volumes increased in all indications and regions. Furthermore, higher sales prices and positive exchange rate effects contributed to significant sales growth. Earnings were also considerably above the level of the previous second quarter. At €833 million, EBIT before special items in the first six months of 2012 already exceeded the amount for the full year 2011 (€810 million).
Increased volumes as well as higher gas prices led to significant sales growth in the Oil & Gas segment. Volumes grew in natural gas trading due to greater demand on spot trading markets. After the suspension of production in Libya from February to October of the previous year, it was possible to continuously produce crude oil there throughout the second quarter of 2012. Earnings before tax therefore considerably exceeded the level of the previous second quarter. Net income in
Oil & Gas declined.
Other posted a decline in sales, largely as a result of the divestiture of the styrenic plastics business, which was contributed to the Styrolution joint venture as of October 1, 2011. Earnings in Other improved as a result of lower provisions for the long-term incentive program, while an expense had been incurred in the previous second quarter.
Business development in the regions
In Europe, sales increased by 9% in the second quarter of 2012. Volumes in the Agricultural Solutions and Oil & Gas segments grew significantly. Sales rose considerably in the Chemicals segment due to portfolio effects. EBIT before special items grew by €467 million to €1.9 billion, thanks to the higher contribution from the Oil & Gas and Agricultural Solutions segments.
In North America, sales in the second quarter fell by 15% in U.S. dollars and by 5% in euro terms. This was mainly the result of lower volumes due to plant shutdowns and the optimization of the supply chain for steam cracker products in the third quarter of 2011. Sales in the Agricultural Solutions segment grew in all indications thanks to high demand. Lower margins in the Petrochemicals division as well as higher fixed costs resulting from plant shutdowns led to a €127 million decline in earnings to €330 million.
Compared with the same period of 2011, sales in the Asia Pacific region were down 1% in local-currency terms and up 9% in euro terms. Positive currency effects more than offset reduced sales prices. Sales rose significantly in the Catalysts division, mainly due to higher sales volumes. Weaker margins, especially in the Petrochemicals division, led to a €57 million decline in earnings to €229 million.
Sales in the South America, Africa, Middle East region rose by almost 1% in local-currency terms and in euro terms. While the business with crop protection products was very successful, sales in the Catalysts division declined due to lower volumes. Earnings in the region decreased by €30 million to €54 million.
http://www.basf.com/group/pressrelease/P-12-334
2012-07-17
P-12-321
- BASF wants to become the world's leading system supplier of functional materials for high-performance batteries
- Research and development activities combined with acquisitions improve technology portfolio and global market access
- Production plant for innovative cathode materials to come on stream in Elyria, USA in Q4 2012
- BASF and Volkswagen are jointly sponsoring an international "Science Award Electrochemistry"
Ludwigshafen, Germany – July 17, 2012 – Over the last few months, BASF has taken several strategic decisions to further strengthen its position in materials for high-performance batteries. Through acquisition of the US companies Ovonic Battery Company and Novolyte Technologies, purchase of Merck's electrolyte activities, conclusion of a license agreement to acquire the lithium iron phosphate technology (LFP) with the LiFePO4+C Licensing AG and participation in Sion Power, BASF has further improved its technology base and global market access for battery materials. Research and development activities have also been stepped up.
Batteries are chemical power plants
“Most materials in lithium-ion batteries of the kind currently used in electric or hybrid cars are based on innovations from chemistry,” said Dr. Andreas Fischer, Vice President Battery Research and Electrochemistry at BASF, in Ludwigshafen/Germany. Especially cathodes, anodes and electrolytes are important for battery performance. “A battery is a chemical power plant in which all the materials have to be optimally matched to each other,” added Fischer. “We have therefore initiated numerous research and development projects for these key components in recent years, with the aim of developing innovative materials for high-performance batteries that will significantly increase the range of electric cars while reducing the cost of the battery.”
In these activities, BASF researchers are also cooperating with numerous national and international universities and research institutes as well as industry partners. One example is the Innovation Alliance HE-Lion (High Energy Lithium-ion Battery) sponsored by the German Federal Ministry for Education and Research and headed by BASF. “In HE-Lion we are collaborating with other companies such as Bosch and VW and numerous universities and research institutes in developing the next generation of lithium-ion batteries,” explained Fischer.
BASF researchers also operate a joint laboratory for the development of new battery materials with the Karlsruhe Institute of Technology (KIT). The two partners are looking to invest about €12 million over the next five years.
BASF is also a founding member and member of the Board of the "Lithium-ion Battery Competence Network" (KLiB) in Ulm, Germany. KLiB is an association of German companies and application oriented research institutes along the lithium-ion battery value chain. The goal is to bundle the competences from industry, science and craft trades in order to strengthen the high-tech and production center Germany.
Lithium-sulfur and lithium-air batteries as technologies of the future
Besides materials for lithium-ion batteries, BASF is also researching future battery concepts such as lithium sulfur and lithium air. “These new technologies promise much higher energy densities and have the potential to further reduce the weight and cost of the batteries,” said Fischer. Here too, BASF is cooperating with external partners from science and industry. “We are working on basic questions relating to new materials and functional components, for example in the research network Electrochemistry and Batteries, with scientific partners from Germany, Switzerland, Israel, the USA and Canada. To increase the service life and energy density of lithium-sulfur batteries, BASF is also cooperating with the US company Sion Power,” added Fischer.
Acquisitions strengthen technology base and global market access
“Over the last few months, we have taken a major stride closer to achieving our goal of becoming the leading supplier of functional materials and components for existing and future lithium-ion batteries,” emphasized Ralf Meixner, Senior Vice President Battery Materials at BASF. “With the latest expansions and additions to our portfolio we have broadened our technology base and our global market access and have further improved our competitive position.”
In February this year BASF acquired the US company Ovonic Battery Company, the world leader in nickel-metal hydride batteries (NiMH batteries). “Besides assuming a leading position in nickel-metal hydride battery technology, we have also acquired the long-standing business relationships with the world's largest battery manufacturers,” explained Meixner. Ovonic, with its high research competence, is also an ideal fit with BASF development projects in the battery materials field.
“The acquisition of the electrolyte business for high performance batteries from Merck announced in February and of Novolyte Technologies in April have also significantly strengthened our position as a global supplier of electrolytes for lithium-ion batteries with production centers in Europe, USA and Asia Pacific,” said Meixner. BASF acquired the already marketed electrolyte products and the research portfolio from Merck. The acquisition of the Novolyte business included the development, manufacture and marketing of high-performance electrolyte formulations with production centers in the USA and China.
Another milestone is BASF's first production plant for cathode materials in Elyria, USA. “Beginning later this year, we will be producing innovative cathode materials at this site,” added Meixner. The facility, with an investment volume of than $50 million, will be one of the world's most cutting-edge production plants for cathode materials.
In March, BASF also signed a long-term license agreement with LiFePO4+C Licensing AG in Muttenz, Switzerland, to acquire global rights for the production and marketing of the innovative cathode material lithium-iron phosphate (LFP). LFP cathode materials can be used in all types of lithium-ion batteries and are most suitable for high-performance applications such as hybrid vehicles and grid storage batteries.
“Our agreement with LiFePO4+C makes BASF the world's only company that can offer its customers the highest-demand cathode materials nickel cobalt manganese and lithium iron phosphate together with a license for their use,” explained Meixner.
The global battery market offers BASF major growth prospects. “We assume that in 2020 the global market potential for batteries for electromobility alone could reach €20 billion,” added Meixner. He estimates the sales potential for BASF at around €500 million. “In a dynamic market, we want to support our customers' global competitiveness as a solution-oriented system supplier of materials for batteries,” said Meixner. “The products are addressed to cell and battery manufacturers. BASF will continue to invest in its own research and development activities, production plants, cooperations and participations.” A total investment in the three-digit million euro range is planned for 2011 to 2016.
BASF and Volkswagen are jointly sponsoring an international "Science Award Electrochemistry"
To motivate top-flight researchers and establish itself even more strongly in the field of electrochemistry and its applications, BASF and Volkswagen are sponsoring the international "Science Award Electrochemistry," which was announced in May. The science award is designed to promote outstanding scientific and engineering achievements and deliver impetus for the development of high-performance energy storage systems. The award will be offered annually from now on, and is addressed to scientists working in academic research worldwide. The prize is worth €50,000. Candidates for the science award can apply at the internet platform www.science-award.com by August 3, 2012. The award ceremony will be held on October 22, 2012 in Wolfsburg, Germany.
About BASF
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success, social responsibility and environmental protection. Through science and innovation we enable our customers in almost all industries to meet the current and future needs of society. Our products and system solutions contribute to conserving resources, ensuring healthy food and nutrition and helping to improve the quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF posted sales of about €73.5 billion in 2011 and had more than 111,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.
About BASF’s Catalysts Division
BASF’s Catalysts division is the world’s leading supplier of environmental and process catalysts. The group offers exceptional expertise in the development of technologies that protect the air we breathe, produce the fuels that power our world and ensure efficient production of a wide variety of chemicals, plastics and other products, including advanced battery materials. By leveraging our industry-leading R&D platforms, passion for innovation and deep knowledge of precious and base metals, BASF’s Catalysts division develops unique, proprietary solutions that drive customer success. Further information on BASF’s Catalysts division is available on the Internet at http://www.catalysts.basf.com/ www.catalysts.basf.com
Source: http://www.basf.com/group/pressrelease/P-12-321
Johnson & Johnson ( $J&J ) is one step closer to a new Zytiga indication that could double its sales. If the company gets its way, U.S. and European regulators will soon approve the prostate cancer drug for patients who've never had chemo. The new use would triple the size of Zytiga's market.
The approval applications are based on a Phase III study that compared Zytiga versus placebo as an add-on to prednisone therapy. The 1,000-plus patient study was unblinded early because its data monitoring committee recommended opening up the control arm to Zytiga therapy. Because of this, no overall survival benefit was apparent. Progression-free survival increased to an estimated 16 months in Zytiga patients versus 8 months in the placebo patients.
After the study was stopped in April, analysts started rejigging their sales forecasts for the drug. Wells Fargo's Larry Biegelsen pointed out that there are twice as many pre-chemo patients as there are post-chemo patients, which currently make up Zytiga's target market. He's reworking his estimates, which called for around $900 million in sales next year. Citi's Bryan Huang figures that the pre-chemo market could be worth $2.5 billion, while post-chemo he estimated at $800 million.
When the study data was presented at ASCO , Biegelsen said his sales estimates for this year might even be too low, at $525 million. Analysts didn't see Dendreon's ( $DNDN ) Provenge as a problem for Zytiga's entry into that pre-chemo market; they figure doctors will prefer the oral Zytiga over the infused-and-personalized Provenge. That remains to be seen, but J&J may soon have the opportunity to test that theory.
http://www.fiercepharma.com/story/bigger-zytiga-market-step-closer-jjs-approval- filings/2012-06-18?utm_medium=nl&utm_source=internal